Human BTN3A2 Protein (BNT-HM2A2)

KACTUS

Human BTN3A2 Protein (BNT-HM2A2)

9

Research Use Only

>95%

BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression.

-20°C or -80°C,-80°C

12352202